衰老中的药理学边界:通过药物重新定位来改变衰老
Andleeb Shahzadi1, Sibel Ozyazgan1, Ufuk Çakatay2
1Department of Medical Pharmacology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, İstanbul, Türkiye.
Advances in pharmacology (San Diego, Calif.)
|July 27, 2025
概括
将现有的药物改为老年疗法提供了一个实用的策略,以对抗由细胞衰老驱动的与衰老相关的疾病. 这种方法通过利用已知的药物特征来加速开发可访问和有效的治疗方法.
科学领域:
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
- 生物医学科学 生物医学科学
背景情况:
- 细胞衰老是衰老和与年龄相关的疾病的重要贡献者.
- 开发新型老年疗法在药物发现和临床转化方面面临挑战.
- 重新利用现有药物为老年治疗提供了更快,更安全,更具成本效益的途径.
研究的目的:
- 根据它们的机制和标来分类老年治疗药物 (老年治疗药物,老年模拟药物,老年阻断剂,老年逆转剂).
- 探索针对特定组织的向策略和优化重新定位的老年治疗药物的剂量.
- 为理解和应用药物重用在针对衰老的干预中提供一个结构化的框架.
主要方法:
- 对具有老年治疗潜力的现有药物的系统审查和分类.
- 对作用机制,分子点和治疗应用的分析.
- 对药物重定向机会,挑战和临床转换途径的评估.
主要成果:
- 基于它们在向细胞衰老中的功能作用的老疗法药物的综合分类.
- 通过组织特异性向和优化剂量,确定提高重定向老年治疗药物的精度和安全性的策略.
- 弥合临床前研究和老年治疗药物的临床应用之间的差距.
结论:
- 药物再利用是开发老疗法药物的务实和有效策略.
- 这种方法加快了与年龄相关疾病的可获得和有效治疗的可用性.
- 重用常规药物具有延长健康寿命和减轻与年龄相关的功能障碍的巨大潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview
8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Prodrugs
2.9K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.9K
Aging
185
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
185
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K


